פריוויג'ן

Country: Israel

Language: Hebrew

Source: Ministry of Health

Active ingredient:

IMMUNOGLOBULINS, NORMAL HUMAN

Available from:

CSL BEHRING LTD., ISRAEL

ATC code:

J06BA02

Pharmaceutical form:

תמיסה לאינפוזיה

Composition:

IMMUNOGLOBULINS, NORMAL HUMAN 100 G/L

Administration route:

תוך-ורידי

Prescription type:

מרשם נדרש

Manufactured by:

CSL BEHRING AG, SWITZERLAND

Therapeutic group:

IMMUNOGLOBULINS, NORMAL HUMAN, FOR INTRAVASCULAR ADM.

Therapeutic area:

IMMUNOGLOBULINS, NORMAL HUMAN, FOR INTRAVASCULAR ADM.

Therapeutic indications:

1. Replacement therapy in- Primary immunodeficiency syndromes such as:- Congenital agammaglobulinaemia and hypogammaglobulinaemia- Common variable immunodeficiency- Severe combined immunodeficiency- Wiskott-Aldrich syndrome- Myeloma or chronic lymphocytic leukaemia with severe secondary hypogammaglobulinaemia and recurrent infections-Children with congenital AIDS and recurrent infections2. Immunomodulation- Immune thrombocytopenic purpura (ITP) in children or adults at high risk of bleeding or prior to surgical interventions to correct the platelet count-Guillain-Barr? syndrome- Kawasaki disease3. Allogeneic bone marrow transplantation

Authorization date:

2016-06-30